Dev Labtech Venture
₹80.00
-3.85 (-4.59%)
23 November, 2024 15:16 BSE: 543848
NSE: DEVLABISIN: INE0NIJ01017
Start SIP in Dev Labtech Venture
Start SIPDev Labtech Venture Performance
Day Range
52 Week Range
Dev Labtech Venture Technicals
EMA & SMA
Current Price
₹80.00
-3.85 (-4.59%)
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- ₹83.90
- 50 Day
- ₹85.49
- 100 Day
- ₹89.07
- 200 Day
- ₹89.54
- 20 Day
- ₹84.99
- 50 Day
- ₹83.55
- 100 Day
- ₹90.08
- 200 Day
- ₹98.67
Dev Labtech Venture Resistance and Support
PIVOT
₹80.92
| Resistance | |
|---|---|
| First Resistance | 81.83 |
| Second Resistance | 83.67 |
| Third Resistance | 84.58 |
| RSI | 44.21 |
| MFI | 32.07 |
| MACD Single Line | -0.26 |
| MACD | -0.76 |
| Support | |
|---|---|
| First Support | 79.08 |
| Second Support | 78.17 |
| Third Supoort | 76.33 |
Dev Labtech Venture Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 14,000 | 1,400,000 | 100 |
| Week | 5,750 | 575,000 | 100 |
| 1 Month | 8,941 | 776,452 | 86.84 |
| 6 Month | 11,784 | 928,815 | 78.82 |
Dev Labtech Venture Result Highlights
Dev Labtech Venture Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Dev Labtech Venture Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-11-15 | Others | Inter alia, 1. To grant approval to make investment(s) in one or more tranches in DEV LABTECH VENTURE INC, a wholly-owned subsidiary of the Company, incorporated in Delaware, USA. |
| 2024-10-25 | Half Yearly Results | |
| 2024-08-08 | Others | Inter alia, 1. Conversion of warrants into the equity shares of the Company to the specified persons only subject to the depositing the balance outstanding amount for conversion of warrants. |
| 2024-06-05 | Others | Inter alia, 1. To consider and approve conversion of warrants into the equity shares of the Company to the other specified persons only subject to the depositing the balance outstanding amount. |
| 2024-05-16 | Audited Results | (Revised) |